Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-25 @ 7:08 PM
Study NCT ID:
NCT04782804
Status:
UNKNOWN
Last Update Posted:
2022-08-18
First Post:
2021-03-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-03
First Submit QC Date:
None
Study First Post Date:
2021-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-16
Last Update Post Date:
2022-08-18
Last Update Post Date Type:
ACTUAL